rdf:type |
|
lifeskim:mentions |
umls-concept:C0015520,
umls-concept:C0015982,
umls-concept:C0021467,
umls-concept:C0021469,
umls-concept:C0040018,
umls-concept:C0162768,
umls-concept:C0278372,
umls-concept:C0441513,
umls-concept:C0599894,
umls-concept:C1527177,
umls-concept:C1879547,
umls-concept:C1883036
|
pubmed:issue |
10
|
pubmed:dateCreated |
2000-3-30
|
pubmed:abstractText |
Recombinant technology was used to produce a new anticoagulant that is preferentially localized and active at the site of the clot.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1524-4539
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:day |
14
|
pubmed:volume |
101
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1158-64
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10715263-Amino Acid Sequence,
pubmed-meshheading:10715263-Antibodies,
pubmed-meshheading:10715263-Antithrombins,
pubmed-meshheading:10715263-Base Sequence,
pubmed-meshheading:10715263-Escherichia coli,
pubmed-meshheading:10715263-Evaluation Studies as Topic,
pubmed-meshheading:10715263-Factor Xa,
pubmed-meshheading:10715263-Fibrin,
pubmed-meshheading:10715263-Genetic Vectors,
pubmed-meshheading:10715263-Hirudins,
pubmed-meshheading:10715263-Humans,
pubmed-meshheading:10715263-Immunoglobulin Variable Region,
pubmed-meshheading:10715263-Molecular Sequence Data,
pubmed-meshheading:10715263-Protein Engineering,
pubmed-meshheading:10715263-Recombinant Fusion Proteins
|
pubmed:year |
2000
|
pubmed:articleTitle |
Construction and functional evaluation of a single-chain antibody fusion protein with fibrin targeting and thrombin inhibition after activation by factor Xa.
|
pubmed:affiliation |
Department of Cardiology, University of Freiburg, Freiburg, Germany. peter@mm31.ukl.uni-freiberg.de
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|